Continuous Glucose Monitoring (CGM): Technologies and Global Markets

Publisher Name :
Date: 09-Dec-2022
No. of pages: 123

Report Scope:

The scope of this study encompasses the current and forecast markets for glucose monitoring, connected pumps and pens, SMBG meters, and test strips. The covered segments are CGM transmitters, receivers and sensors, smart pumps and pens, and self-monitoring blood glucose (SMBG) equipment and test strips. The test strip market numbers refer to all types of test strips with SMBG, and not just test strips as used by CGM users. CGM users also use test strips, but theoretically only for calibrating their CGM devices. The report also includes discussions of the market opportunities, patent scenario, market projections and market shares, competitive landscape, and the key company profiles. The report would also cover the COVID-19 impact on the CGM market.

Report Includes:

- 27 data tables and 28 additional tables

- A detailed overview and an up-to-date analysis of the global markets for continuous glucose monitoring (CGM) devices and technologies

- Analyses of the global market trends, with historic market revenue (sales figures) for 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027

- Highlights of market opportunities for this innovation-driven continuous glucose monitoring devices market, and the major regions and countries involved in market developments

- Estimation of the actual market size and revenue forecast for CGM devices in USD million values, and corresponding market share analysis by technology type, end-user settings, type of diabetes, user age group, and region

- Country specific data and market value analysis for the United States, Canada, Germany, U.K., France, Italy, Japan, China, South Korea, etc.

- Reassessment of the critical issues surrounding CGM transmitters/receivers, self-monitoring blood glucose (SMBG) equipment and test strips, and durable insulin pumps; their recent technological advancements, geographic trends, market dynamics, and adoption trends

- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, financial performance, and segmental revenues

- Review of the key patent grants and patent applications within select CGM technologies

- Company profiles of major players within the industry, including Abbott Laboratories, F. Hoffmann-La Roche, Medtronic PLC, Novo Nordisk, and Sanofi S.A.

Summary:

The global market for continuous glucose monitoring (CGM) devices was valued at $REDACTED in 2021. The market is forecast to grow at a compound annual growth rate (CAGR) of REDACTED% to reach approximately $REDACTED by 2027. In this report, the global market is segmented by technology type, user's age, disease type, end-user settings, and region.

Reasons for Doing This Study:

This study provided detailed information regarding developments in continuous glucose monitoring. The incidence of Type 2 diabetes continues to increase in developed and developing countries, driven by the rise in obesity. Continuous glucose monitoring (CGM) is designed to provide a more accurate way to monitor blood glucose levels, allowing diabetic patients to regulate blood glucose better, decrease the risk of diabetes-related damage to their bodies and ultimately improve their health and decrease healthcare costs.

This BCC Research market research report will increase the awareness of current and developing technologies affecting continuous glucose monitoring devices and markets.

Continuous Glucose Monitoring (CGM): Technologies and Global Markets

Table of Contents
1.1 Chapter 1 Introduction
1.2 Study Goals and Objectives
1.3 Reasons for Doing This Study
1.4 Scope of Report
1.5 What's New in This Update?
1.6 Information Sources
1.7 Research Methodology
1.8 Geographic Breakdown
1.9 Analyst's Credentials
1.10 BCC Custom Research
1.11 Related BCC Research Reports
Chapter 2 Summary and Highlights
2.1 Highlights of the Market for CGM Devices
Chapter 3 Market and Technology Background
3.1 Diabetes
3.1.1 Types of Diabetes Mellitus
3.1.2 Diabetes Diagnosis
3.1.3 Diabetes Prevalence and Global Economic Burden
3.1.4 Treatment of Diabetes
3.1.5 Importance of Glucose Monitoring in Diabetes
3.1.6 SMBG Devices
3.1.7 Noninvasive Blood Glucose Monitoring
3.1.8 Continuous Glucose Monitoring (CGM)
3.1.9 Working to Improve CGM Technology
Chapter 4 Market Breakdown by Technology Type
4.1 Global Market for Continuous Glucose Monitoring (CGM) Devices
4.2 Global CGM Markets
4.3 Global Smart Insulin Pumps and Pens Markets
4.4 Global SMBG Meters and Test Strips Markets
Chapter 5 Market Breakdown by End-User Settings
5.1 CGM Market, by End-User Settings
5.2 CGM Market for Home Use
5.3 Hospital and Clinics
5.4 Others
Chapter 6 CGM Market by Type of Diabetes
6.1 CGM Markets, by Type of Diabetes
6.2 Type 1 Diabetes
6.3 Type 2 Diabetes
6.4 Gestational Diabetes
6.5 Others
Chapter 7 CGM Markets, by User's Age
7.1 CGM Markets, by User's Age
7.2 Children
7.3 Teenagers
7.4 Youth
7.5 Middle-Aged
7.6 Aged
Chapter 8 Market Breakdown by Region
8.1 North America
8.1.1 U.S
8.1.2 Canada
8.2 Europe
8.2.1 Germany
8.2.2 The UK
8.2.3 France
8.2.4 Italy
8.2.5 Rest of Europe
8.3 Asia-Pacific
8.3.1 China
8.3.2 Japan
8.3.3 South Korea
8.3.4 Rest of Asia-Pacific
8.4 Rest of the World
Chapter 9 Patent Review
9.1 Patent Review
Chapter 10 Competitive Landscape
10.1 Market Share Analysis
Chapter 11 COVID-19 Impact on the CGM Market
11.1 COVID-19 Impact on the CGM Market
Chapter 12 Analysis of the Market Opportunities
Chapter 13 Company Profiles
13.1 Major Companies
ABBOTT LABORATORIES
BETA BIONICS, INC.
BIGFOOT BIOMEDICAL
DEXCOM INC.
F. HOFFMANN-LA ROCHE LTD.
INSULET CORP.
LIFESCAN IP HOLDINGS, LLC
MEDTRONIC PLC
NOVO NORDISK A/S
PKVITALITY
SANOFI S.A.
SENSEONICS HOLDINGS INC.
TANDEM DIABETES CARE
YPSOMED AG
13.2 Other Companies
ASCENSIA DIABETES CARE HOLDINGS AG
EMPERRA GMBH E-HEALTH TECHNOLOGIES
GLUCOTRACK, INC.
INTUITY MEDICAL INC.
NEMAURA MEDICAL INC.
NOVIOSENSE BV
QLIBRIUM
SINOCARE INC.

List of Tables
Summary Table : Global Market for CGM, by Technology Type, Through 2027
Table 1 : Top 15 Countries with High Prevalence of Diabetes, 2021
Table 2 : Selected Companies Developing Noninvasive Blood Glucose Monitoring Devices
Table 3 : The Key Approved CGM Devices
Table 4 : Global Market for CGM Devices, by Type, Through 2027
Table 5 : Global Market for CGM, by Region, Through 2027
Table 6 : Global Market for CGM Transmitters and Receivers, and Sensors, Through 2027
Table 7 : Global Market for Smart Insulin Pumps and Pens, by Region, Through 2027
Table 8 : Global Market for Smart Insulin Pumps and Pens, by Type, Through 2027
Table 9 : Global Market for SMBG Equipment, by Region, Through 2027
Table 10 : Global Market for SMBG Meters and Test Strips, by Type, Through 2027
Table 11 : Global Market for CGM, by End-User Settings, Through 2027
Table 12 : Global Market for CGM in Home Use, by Region, Through 2027
Table 13 : Global Market for CGM in Hospitals and Clinics, by Region, Through 2027
Table 14 : Global Market for CGM in Other Settings, by Region, Through 2027
Table 15 : Global Market for CGM, by Diabetes Type, Through 2027
Table 16 : Global Market for CGM in Type 1 Diabetes, by Region, Through 2027
Table 17 : Global Market for CGM in Type 2 Diabetes, by Region, Through 2027
Table 18 : Global Market for CGM in Gestational Diabetes, by Region, Through 2027
Table 19 : Global Market for CGM in Other Conditions, by Region, Through 2027
Table 20 : Global Market for CGM, by User's Age, Through 2027
Table 21 : Global Market for CGM in Children, by Region, Through 2027
Table 22 : Global Market for CGM in Teenagers, by Region, Through 2027
Table 23 : Global Market for CGM in Youth, by Region, Through 2027
Table 24 : Global Market for CGM in Middle-Aged, by Region, Through 2027
Table 25 : Global Market for CGM in Aged, by Region, Through 2027
Table 26 : Global Market for CGM, by Region, Through 2027
Table 27 : North American Market for CGM, Through 2027
Table 28 : European Market for CGM, by Country, Through 2027
Table 29 : Asia-Pacific Market for CGM, by Country, Through 2027
Table 30 : Patent Record and Key Patent Areas of Applicants, 2019-2022
Table 31 : Abbott Laboratories.: CGM Products
Table 32 : Abbott Laboratories: Key Development
Table 33 : Beta Bionics, Inc.: Key Developments
Table 34 : Dexcom Inc.: CGM Products
Table 35 : Dexcom Inc.: Key Development
Table 36 : F. Hoffmann-La Roche: Product Portfolio
Table 37 : F. Hoffmann-La Roche: Key Developments
Table 38 : Insulet Corp.: CGM Products
Table 39 : Insulet Corp.: Key Developments
Table 40 : Lifescan IP Holdings, LLC.: CGM Products
Table 41 : Lifescan IP Holdings, LLC: Key Developments
Table 42 : Medtronic PLC.: CGM Products
Table 43 : Medtronic PLC: Key Developments
Table 44 : Novo Nordisk: Products Portfolio
Table 45 : Novo Nordisk: Key Developments
Table 46 : PKvitality: Key Developments
Table 47 : Sanofi S.A.: Products Portfolio
Table 48 : Sanofi S.A.: Key Developments
Table 49 : Senseonics Holdings, Inc.: Products Portfolio
Table 50 : Senseonics Holdings, Inc.: Key Developments
Table 51 : Tandem Diabetes Care: CGM Products
Table 52 : Tandem Diabetes Care: Key Developments
Table 53 : Ypsomed AG: CGM Products
Table 54 : Ypsomed AG: Key Developments

List of Figures
Summary Figure : Global Market for CGM, by Technology Type, 2019-2027
Figure 1 : Global Diabetic Population, by Region, 2021
Figure 2 : Global Market Shares of CGM Devices, by Type, 2021
Figure 3 : Global Market for CGM, by Region, 2019-2027
Figure 4 : Global Market Shares of CGM Transmitters and Receivers, and Sensors, by Type, 2021
Figure 5 : Advantages of Connected Insulin Delivery Systems
Figure 6 : Global Market for Smart Insulin Pumps and Pens, by Region, 2019-2027
Figure 7 : Global Market Shares of Smart Insulin Pumps and Pens, by Type, 2021
Figure 8 : Global Market for SMBG Equipment, by Region, 2019-2027
Figure 9 : Global Market Shares of SMBG Meters and Test Strips, by Type, 2021
Figure 10 : Global Market Shares of CGM, by End-User Settings, 2021
Figure 11 : Global Market for CGM in Home Use, by Region, 2019-2027
Figure 12 : Global Market for CGM in Hospitals and Clinics, by Region, 2019-2027
Figure 13 : Global Market for CGM in Other Settings, by Region, 2019-2027
Figure 14 : Global Market Shares of CGM, by Diabetes Type, 2021
Figure 15 : Global Market for CGM, by Diabetes Type, 2019-2027
Figure 16 : Global Market for CGM in Type 1 Diabetes, 2019-2027
Figure 17 : Global Market for CGM in Type 2 Diabetes, 2019-2027
Figure 18 : Global Market for CGM in Gestational Diabetes, 2019-2027
Figure 19 : Global Market for CGM in Other Conditions, 2019-2027
Figure 20 : Various Barriers to CGMs Usage, by User's Age
Figure 21 : Global Market Shares of CGM, by User's Age, 2021
Figure 22 : Global Market for CGM in Children, 2019-2027
Figure 23 : Global Market for CGM in Teenagers, 2019-2027
Figure 24 : Global Market for CGM in Youth, 2019-2027
Figure 25 : Global Market for CGM in Middle-Aged, 2019-2027
Figure 26 : Global Market for CGM in Aged, 2019-2027
Figure 27 : Snapshot of Global Market for Continuous Glucose Monitoring, by Region
Figure 28 : Global Market Shares of CGM, by Region, 2021
Figure 29 : U.S. Diabetes Prevalence Statistics
Figure 30 : U.S. Market for CGM, 2019-2027
Figure 31 : Canadian Market for CGM, 2019-2027
Figure 32 : European Market Shares of CGM, by Country, 2021
Figure 33 : German Market for CGM, 2019-2027
Figure 34 : The UK Market for CGM, 2019-2027
Figure 35 : French Market for CGM, 2019-2027
Figure 36 : Italy Market for CGM, 2019-2027
Figure 37 : Rest of European Market for CGM, 2019-2027
Figure 38 : Asia-Pacific Market Shares of CGM, by Country, 2021
Figure 39 : Chinese Market for CGM, 2019-2027
Figure 40 : Japanese Market for CGM, 2019-2027
Figure 41 : South Korean Market for CGM, 2019-2027
Figure 42 : Rest of Asia-Pacific Market for CGM, 2019-2027
Figure 43 : Rest of the World Market for CGM, 2019-2027
Figure 44 : CGM Patent Filings, by Year, 2019-2022
Figure 45 : CGM Patent Filings, by Jurisdiction, 2019-2022
Figure 46 : Patent Filings Shares, by Applicants, 2019-2022
Figure 47 : Global Company Market Shares of CGM Manufacturers, 2021
Figure 48 : CGM Market Opportunity Analysis Overview
Figure 49 : Abbott Laboratories: Annual Revenue, 2019-2021
Figure 50 : Abbott Laboratories: Market Shares, by Business Segment, 2021
Figure 51 : Abbott Laboratories: Market Shares, by Region, 2021
Figure 52 : Dexcom Inc.: Annual Revenue, 2019-2021
Figure 53 : Dexcom Inc.: Market Shares, by Region, 2021
Figure 54 : F. Hoffmann-La Roche: Annual Revenue, 2019-2021
Figure 55 : F. Hoffmann-La Roche: Revenue Share, by Division, 2021
Figure 56 : Insulet Corp.: Annual Revenue, 2020 and 2021
Figure 57 : Insulet Corp.: Market Shares of OmniPod, by Region, 2021
Figure 58 : Medtronic PLC: Annual Revenue, 2019-2021
Figure 59 : Medtronic PLC: Market Shares, by Region, 2021
Figure 60 : Medtronic PLC: Market Shares, by Business Segment, 2021
Figure 61 : Novo Nordisk: Annual Revenue, 2019-2021
Figure 62 : Novo Nordisk: Revenue Share, by Business Segment, 2021
Figure 63 : Sanofi S.A.: Annual Revenue, 2019-2021
Figure 64 : Sanofi S.A.: Revenue Share, by Business Unit, 2021
Figure 65 : Senseonics Holdings, Inc.: Annual Revenue, 2020 and 2021
Figure 66 : Tandem Diabetes Care: Annual Revenue, 2019-2021
Figure 67 : Tandem Diabetes Care: Market Shares, by Region, 2021
Figure 68 : Tandem Diabetes Care: Market Shares, by Business Segment, 2021
Figure 69 : Ypsomed AG: Annual Revenue, 2020 and 2021
Figure 70 : Ypsomed AG: Market Shares, by Region, 2021
Figure 71 : Ypsomed AG: Market Shares, by Business Segment, 2021
  • Global Non-Invasive Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 79
    This report studies The Non-Invasive Glucose Meter market. Noninvasive glucose monitoring refers to The measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from The disease) without drawing blood, puncturing The skin, or causing pain or trauma. The global Non-Invasive Glucose Meter market was valued at US$ 179.5 million in 2023 and is anticipated to reach US$ 271.2 million by 2030, witnessing a CAGR of 6.0% during The......
  • Global Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 106
    Glucose Meter is a medical device for determining The approximate concentration of glucose in The blood. It can also be a strip of glucose paper dipped into a substance and measured to The glucose chart. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking The skin with a lancet, is placed on a disposable test strip that The meter reads and uses to calculate The blood glucose level. The meter the......
  • Global Blood Glucose Testing Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 101
    Blood glucose testing, also known as blood glucose monitoring, is one of The main tools involved in controlling diabetes. Blood glucose testing is The process used to measure The concentration of glucose in your blood. Blood glucose testing can be carried out at home using a blood glucose meter. A blood test involves pricking your finger with a small needle called a lancet, drawing a drop of blood from The finger and applying it to a test strip that has been engaged into a blood gluc......
  • Global Glucose Biosensors Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139
    According to our LPI (LP Information) latest study, the global Glucose Biosensors market size was valued at US$ 3249.7 million in 2023. With growing demand in downstream market, the Glucose Biosensors is forecast to a readjusted size of US$ 3620.7 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Glucose Biosensors market. Glucose Biosensors are expected to show stable growth in the future market. However, product ......
  • Global Artificial Pancreas Devices Systems Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Artificial Pancreas Devices Systems market size was valued at US$ 87 million in 2023. With growing demand in downstream market, the Artificial Pancreas Devices Systems is forecast to a readjusted size of US$ 199.2 million by 2030 with a CAGR of 12.6% during review period. The research report highlights the growth potential of the global Artificial Pancreas Devices Systems market. Artificial Pancreas Devices Systems are expect......
  • Global Blood Glucose Testing Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 130
    According to our LPI (LP Information) latest study, the global Blood Glucose Testing market size was valued at US$ 10710 million in 2023. With growing demand in downstream market, the Blood Glucose Testing is forecast to a readjusted size of US$ 13370 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Blood Glucose Testing market. Blood Glucose Testing are expected to show stable growth in the future market. However......
  • Global Lancing Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Lancing Devices market size was valued at US$ 315 million in 2023. With growing demand in downstream market, the Lancing Devices is forecast to a readjusted size of US$ 439.6 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Lancing Devices market. Lancing Devices are expected to show stable growth in the future market. However, product differentiation,......
  • Global Non-Invasive Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Non-Invasive Glucose Meter market size was valued at US$ 175.6 million in 2023. With growing demand in downstream market, the Non-Invasive Glucose Meter is forecast to a readjusted size of US$ 268 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Non-Invasive Glucose Meter market. Non-Invasive Glucose Meter are expected to show stable growth in the futu......
  • Global Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Glucose Meter market size was valued at US$ 1258 million in 2023. With growing demand in downstream market, the Glucose Meter is forecast to a readjusted size of US$ 1959.5 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Glucose Meter market. Glucose Meter are expected to show stable growth in the future market. However, product differentiation, reduc......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs